JP2008506690A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008506690A5 JP2008506690A5 JP2007521565A JP2007521565A JP2008506690A5 JP 2008506690 A5 JP2008506690 A5 JP 2008506690A5 JP 2007521565 A JP2007521565 A JP 2007521565A JP 2007521565 A JP2007521565 A JP 2007521565A JP 2008506690 A5 JP2008506690 A5 JP 2008506690A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorph
- decitabine
- cancer
- endotherm
- polymorph form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/890,828 | 2004-07-13 | ||
| US10/890,828 US20060014949A1 (en) | 2004-07-13 | 2004-07-13 | Compositions and formulations of decitabine polymorphs and methods of use thereof |
| PCT/US2005/024676 WO2006017278A1 (en) | 2004-07-13 | 2005-07-12 | Compositions and formulations of decitabine polymorphs and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008506690A JP2008506690A (ja) | 2008-03-06 |
| JP2008506690A5 true JP2008506690A5 (https=) | 2008-09-04 |
| JP5159307B2 JP5159307B2 (ja) | 2013-03-06 |
Family
ID=35600347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007521565A Expired - Lifetime JP5159307B2 (ja) | 2004-07-13 | 2005-07-12 | デシタビンポリモルフの組成物及び処方物並びにその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060014949A1 (https=) |
| EP (1) | EP1765076A4 (https=) |
| JP (1) | JP5159307B2 (https=) |
| CN (1) | CN101014246A (https=) |
| AU (3) | AU2005271814B2 (https=) |
| CA (1) | CA2573332A1 (https=) |
| WO (1) | WO2006017278A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| JP5528807B2 (ja) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
| WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| JO2778B1 (en) | 2007-10-16 | 2014-03-15 | ايساي انك | Certain Compounds, Compositions and Methods |
| JP5687687B2 (ja) | 2009-04-06 | 2015-03-18 | 大塚製薬株式会社 | 癌を治療するための（２’−デオキシ−リボフラノシル）−１，３，４，７−テトラヒドロ−（１，３）ジアゼピン−２−オン誘導体 |
| WO2010129211A2 (en) * | 2009-04-27 | 2010-11-11 | Dr. Reddy's Laboratories Ltd. | Preparation of decitabine |
| CN101781347B (zh) * | 2009-12-21 | 2012-09-12 | 南京卡文迪许生物工程技术有限公司 | 地西他滨多晶型物和药用组合物 |
| EP2750768B1 (en) | 2011-08-30 | 2018-10-03 | Astex Pharmaceuticals, Inc. | Decitabine derivative formulations |
| EP2766041B1 (en) | 2011-10-12 | 2018-12-05 | Children's Medical Center Corporation | Combinatorial compositions and methods of treating hemoglobinopathies |
| US20140094598A1 (en) | 2012-10-01 | 2014-04-03 | Johnson Matthey Public Limited Company | Method for the purification of decitabine |
| CN103191144B (zh) * | 2013-04-25 | 2014-06-18 | 李伟丽 | 一种治疗癌症的药物组合物及应用 |
| AU2016287585B2 (en) | 2015-07-02 | 2020-12-17 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical compositions |
| WO2019025256A1 (en) | 2017-08-01 | 2019-02-07 | Bayer Aktiengesellschaft | COMBINATION OF MIDH1 INHIBITORS AND DNA HYPOMETHYLATION (AHM) AGENTS |
| KR20200035438A (ko) | 2017-08-03 | 2020-04-03 | 오쓰까 세이야꾸 가부시키가이샤 | 약물 화합물 및 이의 정제 방법 |
| JP7089603B2 (ja) | 2018-06-11 | 2022-06-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 眼疾患を治療するための脱メチル化 |
| PH12022552250A1 (en) | 2020-02-25 | 2023-11-13 | Otsuka Pharma Co Ltd | Combination decitabine and cedazuridine solid oral dosage forms |
| EP4138843A4 (en) | 2020-04-23 | 2024-07-10 | Southern Research Institute | COMPOSITION FOR THE TREATMENT OF BLOOD CANCER USING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF |
| WO2022020747A1 (en) * | 2020-07-23 | 2022-01-27 | Southern Research Institute | Polymorophs of 5-aza-4'-thio-2-deoxycytidine |
| CN119943194A (zh) * | 2023-11-03 | 2025-05-06 | 中国石油天然气股份有限公司 | 一种分子筛晶胞参数确定方法和装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050899A (https=) * | 1963-12-22 | |||
| CH527207A (de) * | 1968-05-08 | 1972-08-31 | Ceskoslovenska Akademie Ved | Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen |
| DE2012888C3 (de) * | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
| JPS5213741B2 (https=) * | 1972-05-22 | 1977-04-16 | ||
| JPS5527077A (en) * | 1978-08-16 | 1980-02-26 | Shin Meiwa Ind Co Ltd | Solids scraper for sludge dehydrator |
| US6613753B2 (en) * | 2001-02-21 | 2003-09-02 | Supergen, Inc. | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| KR101150250B1 (ko) * | 2001-03-01 | 2012-06-12 | 아보트 래버러토리즈 | 시스-ｆｔｃ의 다형 및 기타 결정형 |
| US20040162263A1 (en) * | 2002-10-31 | 2004-08-19 | Supergen, Inc., A Delaware Corporation | Pharmaceutical formulations targeting specific regions of the gastrointesinal tract |
-
2004
- 2004-07-13 US US10/890,828 patent/US20060014949A1/en not_active Abandoned
-
2005
- 2005-07-12 JP JP2007521565A patent/JP5159307B2/ja not_active Expired - Lifetime
- 2005-07-12 CA CA002573332A patent/CA2573332A1/en not_active Abandoned
- 2005-07-12 EP EP05771356A patent/EP1765076A4/en not_active Withdrawn
- 2005-07-12 CN CNA2005800299116A patent/CN101014246A/zh active Pending
- 2005-07-12 AU AU2005271814A patent/AU2005271814B2/en not_active Ceased
- 2005-07-12 WO PCT/US2005/024676 patent/WO2006017278A1/en not_active Ceased
-
2011
- 2011-02-09 AU AU2011200539A patent/AU2011200539A1/en not_active Abandoned
- 2011-02-09 AU AU2011200540A patent/AU2011200540A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008506690A5 (https=) | ||
| Kumar et al. | Structural, thermal and quantum chemical studies of p-coumaric and caffeic acids | |
| JP2010506932A5 (https=) | ||
| RU2007104518A (ru) | Полиморф рапамицина ii и его применение | |
| JP2016528179A5 (https=) | ||
| PT1612203E (pt) | ''formas cristalinas de cloridrato de (-) - (1r,2r) - 3 -(3-dimetilamino-l-etil - 2 - metilpropil) fenol'' | |
| JP2021504310A5 (https=) | ||
| JP2007532548A5 (https=) | ||
| JP2005520819A5 (https=) | ||
| JP2020512315A5 (https=) | ||
| RU2018101363A (ru) | Кристаллическая форма свободного основания лорлатиниба | |
| JP2014522388A5 (https=) | ||
| JP2020511468A5 (https=) | ||
| RU2019112457A (ru) | Несольватированный кристалл, способ его получения и его применение | |
| JP2003527319A5 (https=) | ||
| JP2022037040A5 (https=) | ||
| JP2015516425A5 (https=) | ||
| JPWO2020165646A5 (https=) | ||
| Borge et al. | Syntheses and characterization of copper metal complexes prepared from chalcone derivatives | |
| JP2019529481A5 (https=) | ||
| WO2019195569A1 (en) | Solid-state forms of abemaciclib, their use and preparation | |
| JP2020083892A5 (https=) | ||
| JPWO2020099923A5 (https=) | ||
| RU2019123279A (ru) | Этан-сульфонатная соль производного хинолина | |
| RU2006120422A (ru) | Новое соединение, соответствующие композиции, способы получения и/или способы лечения |